Compare CSX Corporation (CSX) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CSX Corporation vs Citius Pharmaceuticals Inc — how do they compare? CSX Corporation trades at $50.06 (market cap $92.55B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: CSX Corporation is far larger — about 4625.2× Citius Pharmaceuticals Inc's market cap, and CSX Corporation pays a 1.12% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CSX | CTXR | |
|---|---|---|
Market Cap | $92.55B | $20.01M |
Sector | Industrials | Health |
52-Week High | $53.21 | $1.82 |
52-Week Low | $32.05 | $0.48 |
Enterprise Value | $110.52B | $16.23M |
Dividend Yield | 1.12% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About CSX Corporation
Operating in the Eastern United States, Class I railroad CSX generated revenue near $12.5 billion in 2021. On its more than 21,000 miles of track, CSX hauls shipments of coal (13% of consolidated revenue), chemicals (22%), intermodal containers (16%), automotive cargo (9%), and a diverse mix of other bulk and industrial merchandise.
Read more on CSX →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
